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Abstract
Kaposi’s sarcoma (KS) and its causative agent, Kaposi’s sarcoma associated herpesvirus (KSHV/
HHV-8), a gamma2 herpesvirus, have distinctive geographical distributions that are largely
unexplained. We propose the “oncoweed” hypothesis to explain these differences, namely that
environmental cofactors present in KS endemic regions cause frequent reactivation of KSHV in
infected subjects, leading to increased viral shedding and transmission leading to increased
prevalence of KSHV infection as well as high viral load levels and antibody titers. Reactivation
also plays a role in the pathogenesis of KSHV-associated malignancies. To test this hypothesis, we
employed an in vitro KSHV reactivation assay that measured increases in KSHV viral load in
KSHV infected primary effusion lymphoma (PEL) cells and screened aqueous natural product
extracts from KS endemic regions. Of 4,842 extracts from 38 countries, 184 (5%) caused KSHV
reactivation. Extracts that caused reactivation came from a wide variety of plant families, and
extracts from Africa, where KSHV is highly prevalent, caused the greatest level of reactivation.
Time course experiments were performed using 28 extracts that caused the highest levels of
reactivation. The specificity of the effects on viral replication was examined using transcriptional
profiling of all viral mRNAs. The array data indicated that the natural extracts caused an ordered
cascade of lytic replication similar to that seen after induction with synthetic activators. These in
vitro data provide support for the “oncoweed” hypothesis by demonstrating basic biological
plausibility.
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Much has been learned about the epidemiology and pathogenesis of Kaposi’s sarcoma (KS)
since the discovery in 1994 of the causative agent, Kaposi’s sarcoma-associated Herpesvirus
(KSHV), also known as Human Herpesvirus 8.1 The striking geographical differences in
incidence of classic KS and the equally striking differences in incidence of AIDS KS,
according to HIV risk group, can be partially explained by differences in the prevalence of
KSHV. Prior to the AIDS epidemic, KS was most common in sub-Saharan Africa and
Mediterranean countries but was rare in the US and northern Europe.2,3 Even now, in the
US and Northern Europe, KS is rarely seen in patients who acquire HIV via blood products
or heterosexual sex, but it is common in homosexual men.4
The prevalence of KSHV infection also shows considerable variation geographically and
between HIV risk groups, largely mirroring the variations seen in the incidence of KS.
Prevalence is high in sub-Saharan Africa and some Mediterranean countries and low in most
northern European and Asian populations.5 In Italy, the incidence of KS is higher in the
south than in the centre and north of the peninsula. The prevalence of KSHV accords with
this geographical distribution.6 There are exceptions to this general rule, however. For
instance, the high prevalence of KSHV in The Gambia where the incidence of KS is low is
striking.7 The high prevalence of KSHV in South American Amerindians is also surprising.
Although KS has not been reported in Amerindians, it is possible that this may be due to
lack of ascertainment because of poor access to health care and the low life expectancy
among these populations.8,9 In the US and Europe, KSHV is rare in the general population
but relatively common in homosexual men, explaining the high risk of KS in HIV infected
homosexual men.
Although the variation in the incidence of KS disease can thus be partially explained by
differences in KSHV prevalence, no explanation exists for the variation in KSHV
prevalence, since like other herpesviruses, KSHV is known to have coevolved with the
human species.10 Variation in viral prevalence may be due to host genetic or environmental
risk factors. Host genetic factors likely play an important part in the elevated risk for KS in
elderly men of Jewish descent, since the prevalence of KSHV is not elevated in this
population.11 Similarly, KS risk is 10-fold higher in transplant recipients from Saudi Arabia
than from other areas, despite a modest KSHV prevalence in this population.12 In these
instances, the high risk of KS is likely due to a genetically determined increased risk of
disease amongst infected subjects.
We believe that environmental risk factors are more important than genetic predispositions
in determining the variation in KSHV prevalence and KS risk in many areas and
populations. Although KSHV prevalence is high in Africa, it is not elevated in subjects of
African descent living in the Caribbean.13,14 In a study of STD clinic attendees in London,
we found a high prevalence of KSHV in subjects born in Africa but not in those whose
parents were born in Africa, suggesting that a single generation in a non-African
environment is sufficient to reduce prevalence.14 Conversely, the prevalence of KSHV in
South African blood donors of Northern European descent is 10% (Whitby and Sitas,
unpublished data), compared with estimates of 1–2% in Northern European blood donors
living in Northern Europe.
Unlike other viruses, such as Hepatitis B virus, the relationship between socioeconomic
factors such as household crowding and KSHV prevalence is inconsistent. KSHV is
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common in sub-Saharan Africa but rare in Asian countries where similar, though less
extreme, socioeconomic conditions exist. Moreover, it is also relatively common in affluent
countries such as Italy. Therefore, the role of socioeconomic factors in determining KSHV
transmission and prevalence is unclear.
To elucidate a role for environmental cofactors in KSHV infection and KS disease, we
formulated the “oncoweed hypothesis”: Environmental cofactors present in KSHV endemic
regions cause reactivation of KSHV in latently infected subjects. This leads to an increase in
KSHV shedding and hence transmission and also results in elevated viral loads and antibody
titres. Frequent reactivation and lytic replication not only increases the pool of infected
individuals but lytic replication of KSHV may also be important in KS pathogenesis.15 High
viral load and high antibody titres are known risk factors for KS.16,17 Furthermore, many of
the KSHV genes shown to have transforming properties are expressed during viral
reactivation and in primary KS lesions.18,19
To test the premise of this hypothesis, we developed an in vitro KSHV reactivation assay
that measured increases in viral load in latently KSHV infected cells and used it to screen
natural products for potential environmental cofactors of KSHV infection and disease. The
Natural Products Branch of the National Cancer Institute maintains a repository of aqueous
and organic extracts of land plants, marine invertebrates and fungi collected from numerous
tropical and subtropical countries. These extracts are used to screen for antiviral and
anticancer agents using a variety of techniques. In this study, we reversed the usual rationale
and used the library to screen for agents that reactivate a virus that is associated with human
cancer.
Methods
Selection of natural products extracts
Extracts for testing in the KSHV reactivation assay were selected from the NCI/DTP
anticancer screening library of >2,200 unique microtiter plates, which include 130,000
aqueous and organic plant extracts. Plants and animals were collected from 1989 to the
present under contract to the Developmental Therapeutics Program, National Cancer
Institute, for anticancer screening. Organizations with expertise in the flora and fauna of
specific regions were New York Botanical Garden for Central and South America, Missouri
Botanical Garden for Africa and University of Illinois at Chicago Circle for southeast Asia.
Collectors were responsible for taxonomic identification and preparation of a herbarium
voucher. Detailed collection records and taxonomic information are permanently stored in
an NCI database. Plants were air dried in the field and then transported to the NCI facility at
Frederick, MD for storage (−20°C) until processed.
Dried plants were finely ground using a Holmes Brothers hammermill, extracted by
percolation, first with dichloromethane/ methanol (1:1) and then with water. Organic solvent
was removed by rotary evaporation. Aqueous extract was frozen and lyophilized. Additional
detail of the extraction process can be found at http://npsg.ncifcrf.gov. For microtiter plate
preparation, an aliquot of the lyophilized aqueous extract was solubilized in water and
transferred into a single well of a 96-well plate by a robotic liquid handling system (TECAN
Genesis 150, permanent tip), 88 different extracts per plate. The aqueous extracts in the plate
were again vacuum dried using a Savant Speed-Vac 210 (Thermo), leaving a residue of 50
µg/well. All plants, extracts and microtiter plates were stored in −20°C freezers to prevent
degradation.
Natural products were selected from all over the world but there was a definite bias towards
geographical areas where KS is endemic. The vast majority of extracts (4,572) were from
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land plants, but extracts were included from 86 marine plants, 97 marine animals and 87
fungi. More than 50% of extracts selected were from African countries including Cameroon,
Central Africa Republic, Gabon, Ghana, Madagascar and Tanzania. The remaining extracts
were selected as being representative of the rest of the world, including regions where KS is
rare. Plants were not selected by family or genus but rather represented a wide variety of
groups. Extracts known to be highly toxic to cells in tissue culture (based upon previous
anticancer testing) were excluded. Organic and aqueous extracts were available but
screening was restricted to aqueous extracts, since aqueous components of plants were most
likely to be present as environmental exposures. Aqueous extracts that caused greater than
25% growth inhibition in a panel of 60 transformed cell lines at a concentration of 100 µg/
ml were also excluded.
KSHV quantitative PCR assay
We developed a KSHV quantitative real time PCR assay based on Applied Biosystems
(ABI) technology. The KSHV genomic sequence used for assay design was GenBank record
U75698 derived from the BC-1 cell line.20 Primers and probe were designed to target the
KSHV K6 gene region, viral macrophage inflammatory protein α (v-mip-α), using Gene
Runner software (Version 3.00, Hastings Software) according to ABI guidelines. The
selected primers and probe sequence are as follows:
K6-10F: 5′-CGCCTAATAGCTGCTGCTACGG-3′ (nt 27330-27309)
K6-10R: 5′-TGCATCAGCTGCCTAACCCAG-3′ (nt 27159–27179)
p-K6-10: 5′-FAM-CACCCACCGCCCGTCCAAATTC-TAMRA-3′ (nt 27298-27277)
The primers and probe were synthesized and HPLC purified by Operon (Alameda, CA). The
optimized KSHV K6 master mix consisted of 3 mM magnesium chloride, 0.05% EIA
reagent grade gelatin (Sigma, St. Louis, MO), 0.01% Tween 20 (Sigma, St. Louis, MO), 200
µM each dATP, dCTP, dGTP, 400 µM dUTP, 1 µM forward and reverse primers, 200 nM
probe, 0.1 U/µl AmpErase uracil-N-glycosylase and 1.25 U/µl AmpliTaq Gold polymerase
in TaqMan buffer A (TaqMan PCR Core Reagents kit, Applied Biosystems, Foster City,
CA). PCR reactions contained 40 µl of master mix and 10 µl of test material for a final
volume of 50 µl. The cycling conditions were 2 min hold at 50°C, 95°C hold for 10 min and
45 cycles performed at 95°C for 15 sec, 55°C for 30 sec and an annealing step of 60°C for 1
min. All assays were performed using an ABI Prism 7700 automated detection system that
captured and analyzed the data using the Sequence Detection System software version 1.6.
A 500-bp fragment of the KSHV K6 gene, which includes the 176-bp fragment amplified by
the TaqMan primers, was cloned and used to prepare a plasmid based standard. The standard
curve was prepared by making 10-fold serial dilutions ranging from 10 to 100 copies in TE
buffer (nuclease-free 0.1 M Tris-EDTA buffer (Invitrogen, Carlsbad, CA)) containing 0.1
µg/ml of human placental DNA (Sigma, St. Louis, MO). The Sequence Detection software
performs a linear regression and plots the standard curve. The KSHV K6 standard curve has
a least-squares regression (R2) value of greater than 0.97, which reflects titration accuracy.
The slope of the standard curve is indicative of 90–97% PCR efficiency and the Y intercept
value is consistent with one copy template input. The estimated viral copy numbers for test
samples are determined by interpolation of the sample Ct value onto the K6 standard curve.
The lower limit of detection was 3 copies of KSHV genomic DNA per PCR. In practice, the
KSHV K6 assay sensitivity is 1 copy of KSHV per 1 million cell equivalents in clinical
samples.
Whitby et al. Page 4














Lyophilized aqueous extracts were provided at a concentration of 50 µg per well in 96-well
plates. BCP-1 cells21 latently infected with KSHV were added at a concentration of 2.5 ×
105 cells per well and incubated for 3 days at 37°C, 5% CO2 in RPMI (Invitrogen)
supplemented with 20% FBS (Hyclone, Logan, UT). A 96-well plate of uninduced BCP-1
cells served as the negative control and another plate of BCP-1 cells, induced with 0.3 mM
sodium butyrate, was used as the positive control.
DNA was extracted using either the Qiagen QiAmp 96-well blood extraction kit, (Qiagen,
Valencia CA) or Puregene 96-well kit (Gentra Systems, Minneapolis, MN). Real-time
quantitative PCR assays were performed for KSHV K6 and the cell quantitation marker,
ERV-3, as described above and previously.22,23 Viral load was calculated and expressed as
the number of copies per 105 cells.
BCP-1 cells, like all PEL cell lines, undergo spontaneous reactivation and up to 5% of cells
will be undergoing lytic infection at any time. Differences in KSHV viral load after 72 hr
were used to classify the extracts as activators, inactive or suppressors. A reduction in viral
load compared with the uninduced (negative control) cells therefore suggests that lytic
replication is being inhibited, whereas increased viral load is indicative of reactivation.
Extracts were considered activators if the log10 KSHV viral load was 2 standard deviations
greater than the mean of the viral load in the sodium butyrate stimulated (positive control)
cells (log10 KSHV copies = 7.77). The mean log10 viral load in the sodium butyrate induced
cells was 7.05 (geometric mean = 1.12 × 107 KSHV copies/10 cells with a standard
deviation of 0.36 log10 KSHV copies/ 105 compared with 7.03 (geometric mean = 1.07 ×
107 KSHV copies/105 cells) with a standard deviation of 0.23 log10 KSHV copies/105 in the
uninduced (negative control) BCP-1 cells. Extracts were considered inhibitory if the viral
load was greater than 2 standard deviations less than the log10 mean of the uninduced BCP-1
cells (log10 KSHV copies = 6.57). All remaining extracts were classified as either inactive or
indeterminate. Comparisons between African and non-African extracts were made using the
Likelihood Ratio χ2 test.
Time course experiments
We selected the 28 extracts that showed the most potent activity for follow-up experiments.
These extracts produced viral loads of >9 logs in the initial screen. Replicate natural product
plates were created using the same concentration (50 µg/well) of extracts. BCP-1 cells were
added to each well at a concentration of 2.5 × 105 cells in 200 µl of RPMI 1640 (Invitrogen,
Carlsbad, CA) supplemented with 20% FBS (Hyclone, Logan, UT). Plates were incubated at
37°C, 5% CO2 for 1 to 4 days. One plate was harvested each day for 4 consecutive days.
From each well, 100 µl was added to 1 ml of Trizol (Invitrogen, Carlsbad, CA) and frozen at
−80°C for later RNA extraction. DNA was extracted from the remaining 100 µl using the
QiAmp 96-well blood extraction kit (Qiagen, Valencia, CA), according to the
manufacturer’s instructions. Real-time quantitative PCR assays were performed for KSHV
K6 as described earlier and the cell quantitation marker ERV-3 as previously described.22,23
Viral load was calculated and expressed as KSHV copies per 104 cells.
Negative controls consisted of unstimulated BCP-1 cells and positive controls were BCP-1
cells stimulated with a gradient of sodium butyrate concentrations ranging from 3 to 100
nM. The KSHV viral load estimates for each extract were normalized by subtracting the
average of the negative control (unstimulated BCP-1) viral copy number and dividing by the
corresponding 100 nM sodium butyrate positive control copy number for each day. The data
measure the effect greater than that of butyrate and were thus expressed as standard sodium
butyrate units.
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Real-time PCR based KSHV viral gene expression array
RNA was isolated from 106 cells using RNAzol (Tel-Test, Friendswood, Texas) as
previously described,19 and reverse-transcribed using Superscript-II reverse transcriptase
(Invitrogen, Carlsbad, CA), according to the manufacturers’ recommendations. The cDNA
was diluted to a final volume of 600 µl in distilled water and stored at −80°C The KSHV
real-time QPCR array and analysis have been previously described.18 The final QPCR
reaction contained 2.5 µl of primer mix (final concentration 166 nM), 7.5 µl of 2× SYBR
PCR mix (Applied Biosystems, Foster City, CA) and 5 µl of cDNA.
Viral CT values obtained by real-time QPCR were normalized to gapdh according to dCT =
CT (viral mRNA) – CT (gapdh). The dCT values were imported into ArrayMiner v5.2
(Optimal Design, Brussels, Belgium) and clustered based on standard correlation metric.
Fold induction was calculated by ddCT method (fold = 1.7 exp(dCTmock-Maximum
(dCTinduced)).
Western blotting for K8.1 A/B viral glycoproteins
Supernatants from untreated BCP-1 cells and cells stimulated for 96 hr with extracts from C.
dependens, E. coccinea, C. polystachyus and D.fragrans (top activators identified in screen)
were filtered and then concentrated through a 20% sucrose gradient at 17,000 rpm, 4°C for 2
hr. Virus was resuspended in 300 µl (concentrated 100× original volume). Isolated KSHV
(1.5 µl) from each condition was subjected to electrophoresis in a 7% Tris-Acetate
polyacrylamide gel (Invitrogen, Carlsbad, CA) under reducing conditions. After transfer to
Immobilon-P PVDF membrane (Millipore, Billerica, MA), the blot was probed with mouse
anti-K8.1A/B (Advanced Biotechnologies, Columbia, MD), washed and probed with goat
anti-mouse secondary antibody (Invitrogen, Carlsbad, CA). Chemiluminescence using
Immunstar HRP (Biorad, Hercules, CA) was detected on Lumi-Film (Roche, Indianapolis,
IN).
Electron microscopy
Preparation of cultured cells for EM ultrastructural analysis was described previously.24
Briefly, BCP-1 cells stimulated for 96 hr with extracts from C. dependens, E. coccinea, C.
polystachyus and D. fragrans as well as 0.3 mM sodium butyrate (about 1 × 106/ ml) were
centrifuged at 100g, supernatant aspirated and gently overlaid with 2% glutaraldehyde in
cacodylate buffer (0.1 M, pH. 7.4) followed by post fixation in 1% osmium in same buffer.
The cell pellet was stained en bloc in 0.5% uranyl acetate in acetate buffer (0.1 M, pH 4.0),
dehydrated in graded ethanol and propylene oxide and infiltrated in an equal volume of
epoxy resin and propylene oxide overnight. The sample was embedded in epoxy resin and
cured for 48 hr in 60°C The cured block was thin-sectioned, stained in uranyl acetate and
lead citrate and examined with an EM equipped with a digital camera and operated at 75 kV.
Results
A total of 4,842 extracts from 38 countries were tested for their ability to induce KSHV
reactivation in BCP-1 cells. Most were from land plants but extracts from 86 marine plants,
97 marine animals and 87 species of fungi were included. Usable results were obtained from
3,703 extracts. A total of 2,958 extracts were inactive, 561 reduced levels of spontaneous
KSHV replication and 184 (5.0%) induced viral reactivation above the level of sodium
butyrate, which is the most potent chemical inducer of KSHV reactivation. The degree of
viral reactivation by natural products was significantly higher than that obtained by host
biological response modifiers such as interferon-gamma.25,26
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More than half (2,477) of the extracts with usable results were from African land plants and
126 (5.1%) of these were activators, compared with 58 (4.7%) from other or unknown
geographical regions (Table I). Activators included 3 marine plants, 1 marine animal and 1
fungal extract.
Using likelihood ratio χ2 tests, African plants were more likely to cause reactivation than
non-African plants (p = 0.024: likelihood ratio χ2 = 7.442, 2 df). Of the activating extracts,
the magnitude of activation was greater for those from Africa (log10 mean = 8.41) compared
with those from elsewhere (log10 mean = 8.21, p = 0.044, t-test). These associations were
only weakly statistically significant. There were no activators from Europe or Asia, although
only a small number of extracts from these regions were tested. Somewhat surprisingly, the
proportion of extracts from Central America and the Caribbean and from The Philippines
and Indonesia causing reactivation was higher than for African plants (5.6% and 7.2%,
respectively vs. 5.1%), although the numbers of extracts were relatively small.
Viral activators belonged to a wide variety of plant families (Table II), although consistent
with sampling based only on geography; for many families only a few extracts were tested.
For example, 2 out of 3 samples from the Hypericaceae and 3 out of 7 samples from the
Pittosporaceae were classified as activators. Between 7 and 15% of the extracts from the
Acanthaceae, Boraginaceae, Celastraceae, Leguminosae, Rutaceae and Solanaceae were
classified as activators compared with 5% or less for other families. The 28 natural products
that had the highest reactivation levels in the screening experiment are listed in Table III,
along with the family to which they belong, country of origin and the induced KSHV level
expressed as log10 KSHV copies per 105 cells.
Apparent inhibition of KSHV replication was observed with 555 extracts (15%).These
extracts included 525 land plants, 11 marine plants, 9 marine animals and 10 fungi. We
considered it unlikely that these extracts were specifically inhibiting KSHV replication.
More likely, the reduction in KSHV load that was observed with these extracts was probably
caused by toxic effects of the extracts specific to BCP-1 cells, even though we had excluded
extracts known to cause cytotoxicity in other cell lines. Some of these extracts may cause
specific inhibition of KSHV replication but, since this was not the focus of this study, we
did not attempt to characterize these further, with the exception of 3 extracts selected for the
viral transcription array experiment.
We further characterized the dynamics of reactivation by retesting the 28 most potent
extracts from the initial screen in a 4-day time course experiment over 4 days. Using the K6
real-time quantitative PCR assay, we confirmed the initial screening results for 22 of the
extracts by showing KSHV viral load increases over time (Fig. 1). To further elucidate the
mechanism of reactivation, RNA was extracted from duplicate cell pellets for viral gene
expression analysis using a previously reported viral array18 that queries the entire KSHV
transcriptome by real time quantitative PCR. Four extracts causing high levels of
reactivation, Dracaena fragrans, Chasmanthera dependens, Cleistanthus polystachyus and
Emilia coccinea, were chosen for RNA analysis as well as 3 causing apparent inhibition:
Uvaria angalensia, Keetia carmichailli and Garcinia species.
No mRNAs could be isolated from pellets in experiments using extracts, U. angolensia and
Garcinia species, which caused apparent inhibition, consistent with our assumption that the
natural product extract killed the cells early on. The other results fell into 2 categories; E.
coccinea, C. dependens and D. fragrans caused only minimal changes in levels of 3
different cellular mRNAs over time, suggesting that the extract did not affect cell viability or
basic cellular transcription (Fig. 2a). In contrast, extracts from K. carmichailli and C.
polystachyus caused a rapid decrease in cellular mRNA levels between 24 and 48 hr post
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exposure, suggesting a deleterious effect on viability or down regulation of basic cellular
transcription. On the basis if this result, we normalized all data to the level of gapdh for each
sample at each time point.
To determine whether the extracts were specifically causing KSHV reactivation, we first
quantified the levels of 2 early viral mRNAs: K14 and ORF57 (Fig. 2b). All 3 of the extracts
causing apparent decrease of KSHV replication exhibited significant signs of cellular
toxicity. We were therefore unable to demonstrate any specific effects on KSHV replication
by these extracts. In contrast, for extracts causing activation, E. coccinea, C. polystachyus,
C. dependens and D. fragrans, the 2 viral mRNAs showed a different pattern than the
cellular mRNAs. Levels for K14 and ORF57 increased over time up to and beyond the level
of gapdh, which is indicative of KSHV lytic reactivation. By comparison, the 2 cellular
mRNAs, c-myc and actin showed little or no change, indicating that the effect was specific
for viral transcripts. Table IV shows fold induction relative to mock treated cells for selected
mRNAs, representing the different kinetic classes of genes. All classes were induced relative
to mock treatment.
To evaluate the effects of E. coccinea, C. polystachyus, C. dependens and D. fragrans
extracts on all KSHV mRNAs, we performed cluster analysis of the viral array data as
shown in Figure 3. Most KSHV mRNAs were induced upon exposure to the natural
products and with similar kinetics, as shown by the gradual shift from blue (low levels) to
black (median level) to red (high levels) over time. This suggested that the transcriptional
changes were the result of an ordered cascade of lytic reactivation rather than activation of
random viral promoters by the extract. The RNA transcription data indicate that the
increases in viral load observed with our real time PCR assay are a consequence of specific
viral reactivation as a result of exposure to the natural product extracts.
To determine whether viral reactivation by natural products resulted in virion production, we
filtered and concentrated supernatants from untreated BCP-1 cells and cells treated with C.
dependens, E. coccinea, C. polystachyus and D. fragrans for 96 hr. Immunoblotting of the
KSHV late-lytic viral protein K8.1 A/B detected the expected 68–72 kDa broad band of
virion-associated glycoprotein27 in samples from cells exposed to the 4 extracts, suggesting
natural product reactivation induced a full lytic cycle of the virus (Fig. 4).K8.1 was not
detected in the supernatant from the untreated BCP-1 cells. Cells from this experiment were
processed for electron microscopy. Immature and mature virions were present in cells
treated with all 4 extracts as well as the positive control. Representative virions are shown in
Figure 5.
Discussion
We have demonstrated that aqueous extracts of natural products collected from African
countries known to have a high prevalence of KSHV infection and endemic KS can cause
reactivation of KSHV in latently infected PEL cells. This supports the “oncoweed”
hypothesis by providing a biological mechanism that may help to explain geographic
variations in KSHV reactivation rates. Higher reactivation rates may explain higher
prevalence, viral loads and transmission frequency in KS endemic regions.
Some caution must be applied to the interpretation of these data. The plants in the NCI
repository were not collected to be representative of the flora of specific geographical areas
but were selected for possibly having therapeutic potential against common cancers. Few
extracts were available from regions with very low KSHV prevalence. The percentage of
extracts inducing activation was only slightly higher if they were collected from African
versus non African countries. In addition, a surprisingly high proportion of extracts from
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Central American and Caribbean plants, as well as plant extracts from The Philippines and
Indonesia caused KSHV reactivation. These results warrant further study. However, among
the activating extracts, the level of viral reactivation by African extracts was significantly
higher than that from non-African extracts. This is evident from Table III which shows that
25 of the 28 most potent extracts were from Africa. The viral loads after reactivation with
natural products exceeded those obtained after reactivation with known chemical inducers
and host response modifiers. This supports the “oncoweed” hypothesis, since highly active
extracts are more likely to have a biological effect on exposed subjects.
The plants causing activation included many that are used in traditional medicines, for
basket making or as food. For example, C. dependens, P. febrifugum, M. lanceolota, E.
coccinacea and B. antidysenterica are all used in traditional medicines. S. persica twigs are
used for teeth cleaning and V. simplicifolia is used to make wooden bowls and spoons.
Consequently, exposure of KSHV infected individuals to the active ingredients contained in
these plants is plausible. Wojcicki recently described traditional practices associated with
saliva exchange in sub-Saharan Africa. Many of these involved chewing of herbs by
traditional healers and by mothers before a mixture of herbs and saliva were used for
treatment.28 If the herbs used caused KSHV reactivation, this might be a very efficient route
of KSHV transmission, since we know that viral shedding occurs in saliva.29–31
A role for environmental cofactors has been proposed in the etiology of endemic Burkitt’s
lymphoma (BL), a monoclonal B cell malignancy of children that is caused by Epstein Barr
virus and has a distinct geographical distribution in sub-Saharan Africa. One well defined
cofactor is holoendemic malaria but it has also been proposed that exposure to sap from the
plant Euphorbia tirucalli, a member of the Euphorbiaceae family may be an additional
environmental cofactor.32–35 Laboratory studies have shown that E. tirucalli extracts or
latex enhance EBV induced transformation,36 reduce Epstein-Barr virus (EBV) specific
cellular immunity37 and cause reactivation of EBV lytic replication.35 These studies
demonstrate the biological plausibility of a role for E. tirucalli as a cofactor in endemic
Burkitt’s lymphoma, although definitive epidemiological studies have yet to be reported.
There are additional reports of similar activities in related Euphorbiaceae extracts36,38 and in
extracts from the unrelated Aleurites fordii,39 indicating that additional environmental
factors may be important in EBV pathology. E. tirucalli, related Euphorbiaceae and
Aleurites fordii are known to contain high levels of phorbol esters which are known inducers
of EBV lytic reactivation.
There is considerable overlap between the regions of sub-Saharan Africa known to be
endemic for KS and those where endemic BL occurs, although there are also important
differences in the local distribution of the 2 diseases.2 We did not investigate reactivation of
EBV in this study but it is plausible that some natural products may exert effects on EBV as
well as KSHV. Of interest, C. polystachyus, an extract that caused high levels of KSHV
reactivation in this study, is a member of the Euphorbiaceae. This family includes E.
tirucalli, the plant studied as a potential cofactor for endemic BL. It is unlikely, however,
that the biological activity of the extracts identified in this study was related to the presence
of phorbol esters, since we used only aqueous extracts and phorbol esters would be found in
organic extracts. Chemical fractionation of the most potent extracts to determine the active
components is planned.
We conclude that environmental factors may play an important role in the epidemiology of
KSHV. Such factors may be involved in enhancing transmission of KSHV in KS endemic
areas and in accelerating progression to KS disease in KSHV latently infected individuals by
increasing the viral reactivation frequency. Our extensive screening data provide support for
this “oncoweed” hypothesis by demonstrating for the first time biological plausibility.
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Further epidemiological and laboratory studies are needed to fully understand the role of
environmental cofactors in KSHV infection and disease.
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Time course experiment with 28 extracts that caused the highest increases in KSHV viral
load in the initial screen. The names and country of origin of the extracts are listed in Table
III. The results are shown relative to the viral load observed in sodium butyrate induced
cells. The standard deviation was calculated from the results of day 1 for all samples. Black
dashed lines indicate one and a half standard deviations above and below the normalized
average unstimulated control values for each day.
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(a) Raw CT values for three cellular mRNAs, namely actin (blue squares), gapdh (red
triangles) and c-myc (black circles). CT values are depicted on the vertical axis and
correspond to the level of mRNA on a logarithmic scale. Higher CT values indicate lower
mRNA levels. Hence, a CT = 40, for the negative nontemplate control (NTC) lanes
indicated no amplification. We used BCP-1 cells as a positive control. As expected, gapdh
mRNA is more abundant than actin, which in turn is more abundant than c-myc mRNA, as
indicated by their relative CT values. Moreover, a 1:2 dilution of the input cDNA pool
resulted in the same, reproducible and significant increase in CT for each mRNA, affirming
the quantitative nature of our analysis. (b) dCT values for 2 KSHV mRNAs, K14 (red
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circles) and ORF57 (blue squares) and 2 cellular mRNAs, actin (black open circles) and c-
myc (black triangles) at days 0, 1, 2, 3 and 4 after exposure to natural product extracts.
Lower CT values correspond to higher mRNA levels on a log 2 scale, and 0 indicates
mRNA levels equivalent to gapdh mRNA.
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Heatmap representation of hierarchical clustering of dCT values for 73 KSHV mRNAs.
Gapdh mRNA is present at an intermediate level, indicated by the black color. High
abundance mRNAs are in red. The topmost group of viral mRNAs was present at high levels
(indicated by red color in each sample) and changed very rapidly and significantly. A second
group changed from low abundance (blue) to medium abundance (black). The third group of
KSHV mRNAs increased slowly over time and only at the last time point exhibited levels
above the median (red). In this depiction, black indicates equivalency to the level of gapdh,
because individual genes are not normalized, which preserves information on the relative
Whitby et al. Page 16













levels of each mRNA to one another. Primer pairs that amplified splice site specific mRNAs
were excluded because the relative PCR efficiency was not comparable.
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KSHV virion production in supernatant from BCP-1 cells stimulated with extracts from C.
dependens, E. coccinea, C. polystachyus and D. fragrans. Concentrated cell supernatants
from untreated BCP-1 cells and extract exposed cells were run on a denaturing
polyacrylamide gel and the proteins were transferred to a PVDF membrane. Immunoblotting
for reactivity of the late lytic glycoprotein K8.1A/B demonstrated KSHV virion production
in the cells treated with all 4 extracts but not in the untreated BCP-1 cells.
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Electron microscopy of BCP-1 cells stimulated with extracts from C. dependens, E.
coccinea, C. polystachyus and D. fragrans demonstrated the production of typical
herpesvirus virions. Immature and mature particles were observed in cells treated with all 4
extracts as well as the positive control (sodium butyrate). Panels A and B show immature
particles assembled in the nucleus. Panel C shows mature particles in a cytoplasmic vacuole.
Panel D shows an extracellular mature particle. The scale bar represents 200 nm.
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TABLE I
Natural Products Causing KSHV Reactivation by Geographical Region
Region Total products
tested Inactive (%) Activators (%) Inhibitors (%)
Africa 2,477 2,010 (81.1) 126 (5.1) 341 (13.8)
Non-Africa and unknown: 1226 948 (77.3) 58 (4.7) 220 (17.9)
   Asia and Europe 40 33 (82.5) 0 7 (17.5)
   Central America and Caribbean 245 193 (78.7) 14 (5.6) 38 (15.5)
   South America 284 210 (73.9) 9 (3.2) 65 (22.9)
   Philippines and Indonesia 415 311 (74.9) 30 (7.2) 74 (17.8)
   Unknown 242 201 (83.4) 5 (2.1) 36 (14.9)













Whitby et al. Page 21
TABLE II
Plant Families from which 5% or More Extracts Produced KSHV Reactivation
Plant family Number of extractsscreened Activators (%)
Acanthaceae 27 4 (14.8)
Apocynaceae 121 6 (5.0)
Asteraceae 79 4 (5.0)
Boraginaceae 24 2 (8.3)
Caesalpiniaceae 163 8 (4.9)
Celastraceae 57 4 (7.0)
Hypericaceae 3 2 (67.0.)
Leguminosae 31 3 (9.7)
Mimosaceae 66 3 (5.0)
Moraceae 109 6 (5.5)
Pittosporaceae 7 3 (43.0)
Rutaceae 42 4 (9.5)
Solanaceae 32 3 (9.4)
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TABLE III
Name, Family and Country of Origin of Natural Products from which Aqueous Extracts Produced the Highest
Levels of KSHV Reactivation in Initial Screen
Name Family Country of origin Log copiesper 105 cells
Chasmanthera dependens Menispermaceae Tanzania 10.36
Lepistemon owariensis Convolvulaceae Tanzania 10.32
Chenopodium fasciculosum Chenopodiaceae Tanzania 10.08
Acacia amythethophylla Mimosaceae Tanzania 10.00
Vepris simplicifolia Rutaceae Tanzania 9.96
Dalbergia ecastaphyllum Fabaceae Ghana 9.94
Not identified1 Leguminoseae Papua New Guinea 9.88
Pittosporum verticillatum Pittosporaceae Madagascar 9.83
Dracaena fragrans Agavaceae Tanzania 9.74
Cleistanthus polystachyus Euphorbiaceae Cameroon 9.71
Astripomoea grantii Convolvulaceae Tanzania 9.70
Not identified2 Not Identified Philippine Islands 9.57
Eugenia soyauxii Myrtaceae Gabon 9.51
Psorospermum febrifugum Hyperiaceae Tanzania 9.51
Maesa lanceolata Myrsinaceae Tanzania 9.45
Emilia coccinea Asteraceae Tanzania 9.30
Erythrina dominguezii Leguminosae Bolivia 9.30
Salacia whytei Celastraceae Gabon 9.28
Salvadora persica Salvadoraceae Tanzania 9.28
Brucea antidysenterica Simaroubaceae Tanzania 9.26
Chlorophytum blepharophyllum Liliaceae Tanzania 9.26
Ekebergia benguelensis Meliaceae Tanzania 9.23
Cnestis ferruginea Connaraceae Cameroon 9.20
Stericulia tragacantha Sterculiaceae Gabon 9.18
Testulea gabonensis Ochnaceae Gabon 9.15
Datura stramonium Solanaceae Tanzania 9.15
Canavalia rosea Fabaceae Ghana 9.04
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TABLE IV
Maximum Fold Induction by Natural Product Extracts for Selected mRNAS
Gene E. coccinea C. polystachyus C. dependens D. fragrans
ORF 26 214 614 586 658
ORF 29 740 2602 1231 1155
ORF 50 19 127 25 36
ORF 57 103 294 332 363
K8.1 61 63 103 93
c-myc 2 2 2 1.8
Int J Cancer. Author manuscript; available in PMC 2010 April 21.
